1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th July 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

'Conditions related to ME/CFS' news and research

Post and discuss news and research related to conditions potentially related to ME/CFS' including IBS, POTS, fibromyalgia, post-treatment lyme disease, Gulf War Illness.

Page 34 of 39
Sort By:
Title Start Date
Replies Views
Last Message ↑
  1. EndME

    Regulatory T cells shield muscle mitochondria from interferon-γ–mediated damage to promote the beneficial effects of exercise, 2023, Mathis et al

    EndME, Nov 4, 2023
    Replies:
    17
    Views:
    988
    duncan
    Nov 8, 2023
  2. Sly Saint

    Case Report: Rapid and partially persistent, improvements of anorexia nervosa and probable ME/CFS upon metreleptin treatment, 2023, Antel et al

    Sly Saint, Oct 18, 2023
    Replies:
    5
    Views:
    752
    Dolphin
    Nov 9, 2023
  3. EndME

    Science: Anthony Fauci on becoming the ‘devil’ and a warning for his successor, Sept 2023

    EndME, Sep 27, 2023
    Replies:
    16
    Views:
    1,374
    EndME
    Nov 11, 2023
  4. EndME

    SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy

    EndME, Nov 15, 2023
    Replies:
    1
    Views:
    446
    EndME
    Nov 15, 2023
  5. EndME

    Herpes simplex virus 2 serology is associated with thinner whole-brain cortex in community-dwelling older adults, 2023, Gutierrez et al

    EndME, Nov 18, 2023
    Replies:
    0
    Views:
    403
    EndME
    Nov 18, 2023
  6. Andy

    Validation of symptom measures in patients under investigation for postural orthostatic tachycardia syndrome (POTS):... 2023 Iris Knoop, Moss-Morris

    Andy, Nov 19, 2023
    Replies:
    3
    Views:
    499
    Trish
    Nov 19, 2023
  7. EndME

    Dazodalibep (VIB4920/HZN4920) in Sjögren’s Subjects with an Unacceptable Symptom Burden: Safety and Efficacy from a Phase 2, Randomized, Double-Blind

    EndME, Nov 19, 2023
    Replies:
    2
    Views:
    681
    Jonathan Edwards
    Nov 20, 2023
  8. EndME

    Chikungunya-virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans, 2023, Chang et al

    EndME, Nov 22, 2023
    Replies:
    0
    Views:
    396
    EndME
    Nov 22, 2023
  9. Andy

    Treatment and life goals among veterans with Gulf War illness 2023 Sullivan et al

    Andy, Dec 1, 2023
    Replies:
    3
    Views:
    544
    Sean
    Dec 3, 2023
  10. Kalliope

    Improvement in chronic pelvic pain, orthostatic intolerance and interstitial cystitis symptoms after treatment of pelvic vein insufficiency, 2023

    Kalliope, Dec 6, 2023
    Replies:
    0
    Views:
    469
    Kalliope
    Dec 6, 2023
  11. Andy

    Depression is the most significant independent predictor of fatigue in patients with primary Sjögren’s syndrome 2023 Ayar et al

    Andy, Dec 6, 2023
    Replies:
    10
    Views:
    661
    Sean
    Dec 9, 2023
  12. Andy

    The lower Saint Lawrence River region of Quebec, a hot spot for sheepfold-associated Q fever in Canada: Review of 258 cases, 2023, Dolcé et al

    Andy, Dec 9, 2023
    Replies:
    0
    Views:
    404
    Andy
    Dec 9, 2023
  13. Andy

    Efficient assessment of brain fog and fatigue: Development of the Fatigue and Altered Cognition Scale (FACs) 2023 Elliott et al

    Andy, Dec 12, 2023
    Replies:
    0
    Views:
    447
    Andy
    Dec 12, 2023
  14. EndME

    FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis, 2023, Kihara et al

    EndME, Dec 12, 2023
    Replies:
    0
    Views:
    371
    EndME
    Dec 12, 2023
  15. Midnattsol

    Hypothesis Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis, 2023, Vietzen et al.

    Midnattsol, Oct 17, 2023
    Replies:
    6
    Views:
    979
    Jonathan Edwards
    Dec 13, 2023
  16. EndME

    Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study, 2023, McKAy et al

    EndME, Dec 16, 2023
    Replies:
    1
    Views:
    494
    Hutan
    Dec 17, 2023
  17. Andy

    Management perspectives from patients with fibromyalgia experiences with the healthcare pathway: a qualitative study 2023 Kachaner et al

    Andy, Dec 19, 2023
    Replies:
    0
    Views:
    402
    Andy
    Dec 19, 2023
  18. Andy

    Social support in low-income women with [FM] from ... Tenerife (Canary Islands, Spain) 2023 Martín Pérez et al

    Andy, Dec 23, 2023
    Replies:
    0
    Views:
    375
    Andy
    Dec 23, 2023
  19. EndME

    Preprint Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro, 2023, Nair et al

    EndME, Dec 28, 2023
    Replies:
    0
    Views:
    309
    EndME
    Dec 28, 2023
  20. EndME

    Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells, 2024, Gottlieb+

    EndME, Jan 8, 2024
    Replies:
    0
    Views:
    318
    EndME
    Jan 8, 2024
Showing threads 661 to 680 of 764

Thread Display Options

Loading...
Page 34 of 39